Cargando…

Novel proteasome inhibitor delanzomib sensitizes cervical cancer cells to doxorubicin-induced apoptosis via stabilizing tumor suppressor proteins in the p53 pathway

Cervical cancer, the third most commonly occurring cancer, is the second leading cause of cancer related mortality among women. Aberrant ubiquitination and proteasome activity, both human papillomavirus and tumor derived, have been shown to contribute to tumor angiogenesis, proliferation, and invasi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guo, Kevin Y., Han, Lili, Li, Xinyu, Yang, Andrew V., Lu, Jiaxiong, Guan, Shan, Li, Hui, Yu, Yang, Zhao, Yanling, Yang, Jianhua, Zhang, Hong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5768391/ https://www.ncbi.nlm.nih.gov/pubmed/29371974 http://dx.doi.org/10.18632/oncotarget.23166

Ejemplares similares

Delanzomib, a novel proteasome inhibitor, sensitizes breast cancer cells to doxorubicin‐induced apoptosis
por: Wang, Mopei, et al.
Publicado: (2019)

Second-generation proteasome inhibitor carfilzomib sensitizes neuroblastoma cells to doxorubicin-induced apoptosis
por: Guan, Shan, et al.
Publicado: (2016)

TAK1 inhibitor 5Z-7-oxozeaenol sensitizes cervical cancer to doxorubicin-induced apoptosis
por: Guan, Shan, et al.
Publicado: (2017)

Novel proteasome inhibitor ixazomib sensitizes neuroblastoma cells to doxorubicin treatment
por: Li, Haoyu, et al.
Publicado: (2016)

Delanzomib, a Novel Proteasome Inhibitor, Combined With Adalimumab Drastically Ameliorates Collagen-Induced Arthritis in Rats by Improving and Prolonging the Anti-TNF-α Effect of Adalimumab
por: Wang, Lei, et al.
Publicado: (2021)

Novel MDM2 inhibitor SAR405838 (MI-773) induces p53-mediated apoptosis in neuroblastoma
por: Lu, Jiaxiong, et al.
Publicado: (2016)

Oral Proteasomal Inhibitors Ixazomib, Oprozomib, and Delanzomib Upregulate the Function of Organic Anion Transporter 3 (OAT3): Implications in OAT3-Mediated Drug-Drug Interactions
por: Fan, Yunzhou, et al.
Publicado: (2021)

Second-generation proteasome inhibitor carfilzomib enhances doxorubicin-induced cytotoxicity and apoptosis in breast cancer cells
por: Shi, Yonghua, et al.
Publicado: (2016)

Next-generation proteasome inhibitor MLN9708 sensitizes breast cancer cells to doxorubicin-induced apoptosis
por: Wang, Hao, et al.
Publicado: (2016)

P53: Stability from the Ubiquitin–Proteasome System and Specific 26S Proteasome Inhibitors
por: do Patrocinio, Andressa Barban, et al.
Publicado: (2022)

Emerging Roles of the Tumor Suppressor p53 in Metabolism
por: Yu, Lili, et al.
Publicado: (2022)

Novel multi-targeted ErbB family inhibitor afatinib blocks EGF-induced signaling and induces apoptosis in neuroblastoma
por: Mao, Xinfang, et al.
Publicado: (2016)

Crucial Role of TSC-22 in Preventing the Proteasomal Degradation of p53 in Cervical Cancer
por: Yoon, Cheol-Hee, et al.
Publicado: (2012)

Ocotillol Enhanced the Antitumor Activity of Doxorubicin via p53-Dependent Apoptosis
por: Wang, Hongbo, et al.
Publicado: (2013)

The novel proteasome inhibitor carfilzomib activates and enhances extrinsic apoptosis involving stabilization of death receptor 5
por: Han, Bo, et al.
Publicado: (2015)

Lysophosphatidic acid protects cervical cancer HeLa cells from apoptosis induced by doxorubicin hydrochloride
por: Wang, Xibo, et al.
Publicado: (2022)

PEPD is a pivotal regulator of p53 tumor suppressor
por: Yang, Lu, et al.
Publicado: (2017)

A modified p53 enhances apoptosis in sarcoma cell lines mediated by doxorubicin
por: Tang, H-J, et al.
Publicado: (2004)

Structure and Stability Insights into Tumour Suppressor p53 Evolutionary Related Proteins
por: Pagano, Bruno, et al.
Publicado: (2013)

DBC1 Functions as a Tumor Suppressor by Regulating p53 Stability
por: Qin, Bo, et al.
Publicado: (2015)

The tumor suppressor Hic1 maintains chromosomal stability independent of Tp53
por: Szczepny, Anette, et al.
Publicado: (2018)

Isoquercitrin protects HUVECs against high glucose-induced apoptosis through regulating p53 proteasomal degradation
por: Liu, Libo, et al.
Publicado: (2021)

Doxorubicin resistant cancer cells activate myeloid-derived suppressor cells by releasing PGE(2)
por: Rong, Yuan, et al.
Publicado: (2016)

Tumor suppressor OTUD3 induces growth inhibition and apoptosis by directly deubiquitinating and stabilizing p53 in invasive breast carcinoma cells
por: Pu, Qian, et al.
Publicado: (2020)

Wip1 inhibitor GSK2830371 inhibits neuroblastoma growth by inducing Chk2/p53-mediated apoptosis
por: Chen, Zhenghu, et al.
Publicado: (2016)

Sesamin inhibits cervical cancer cell proliferation by promoting p53/PTEN-mediated apoptosis
por: Kuo, Tian-Ni, et al.
Publicado: (2020)

poly(I:C) synergizes with proteasome inhibitors to induce apoptosis in cervical cancer cells
por: Meng, Xueqiong, et al.
Publicado: (2022)

Low RNA stability signifies strong expression regulatability of tumor suppressors
por: Gao, Xinlei, et al.
Publicado: (2023)

The Regulation of Tumor Suppressor p63 by the Ubiquitin-Proteasome System
por: Armstrong, Stephen R., et al.
Publicado: (2016)

Serpinc1 Acts as a Tumor Suppressor in Hepatocellular Carcinoma Through Inducing Apoptosis and Blocking Macrophage Polarization in an Ubiquitin-Proteasome Manner
por: Xu, Dacai, et al.
Publicado: (2021)

TAK1 inhibitor NG25 enhances doxorubicin-mediated apoptosis in breast cancer cells
por: Wang, Zhenyu, et al.
Publicado: (2016)

A chewing proteasome is stabilized
por: Robinson, Richard
Publicado: (2007)

Long noncoding RNA NONMMUT015745 inhibits doxorubicin-mediated cardiomyocyte apoptosis by regulating Rab2A-p53 axis
por: Cai, Hongjing, et al.
Publicado: (2022)

Proteasome inhibition mediates p53 reactivation and anti-cancer activity of 6-Gingerol in cervical cancer cells
por: Rastogi, Namrata, et al.
Publicado: (2015)

Proteasome inhibitor lactacystin enhances cisplatin cytotoxicity by increasing endoplasmic reticulum stress-associated apoptosis in HeLa cells
por: XU, YE, et al.
Publicado: (2015)

Proteasome inhibitor-induced autophagy in PC12 cells overexpressing A53T mutant α-synuclein
por: LAN, DANMEI, et al.
Publicado: (2015)

Inhibitory Effect of Tumor Suppressor p53 on Proinflammatory Chemokine Expression in Ovarian Cancer Cells by Reducing Proteasomal Degradation of IκB
por: Son, Deok-Soo, et al.
Publicado: (2012)

USP47-Mediated Deubiquitination and Stabilization of TCEA3 Attenuates Pyroptosis and Apoptosis of Colorectal Cancer Cells Induced by Chemotherapeutic Doxorubicin
por: Hou, Xiaodan, et al.
Publicado: (2021)

Chidamide Combined With Doxorubicin Induced p53-Driven Cell Cycle Arrest and Cell Apoptosis Reverse Multidrug Resistance of Breast Cancer
por: Cao, Lixia, et al.
Publicado: (2021)

Proteasome inhibitor bortezomib stabilizes and activates p53 in hematopoietic stem/progenitors and double-negative T cells in vivo
por: Xue, Yuezhen, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_lm33u7stj11h9vsnfjljieimj0